Jonathan Rigby
Patrimonio netto: 35 630 $ in data 31/10/2026
Patrimonio netto: 35 630 $ in data 31/10/2026
Jonathan M.
N.
Rigby was the founder of Zogenix, Inc., established in 2006, where the title held was Vice President-Business Development from 2006 to 2010.
Current jobs include President, Chief Executive Officer & Director at Sernova Biotherapeutics, Inc. starting in 2025; Chairman of the Association of Needle-Free Injection Manufacturers since 2010; Chairman & Chief Business Officer at BioPlus Acquisition Corp.
since 2021; Director at Thermalin, Inc.; Director at Aurimi Therapeutics, Inc. since 2021; Director at ReAlta Life Sciences, Inc.; Director at Exciting Instruments Ltd.; and Independent Director at Oncolytics Biotech, Inc. since 2022.
Former jobs include President, Chief Executive Officer & Director at SteadyMed Ltd. from 2011 to 2020; President, Chief Executive Officer & Director at SteadyMed Therapeutics, Inc. from 2011 to 2019; President, Group CEO & Director at Revolo Biotherapeutics Ltd. from 2020 to 2024; Chairman at CollPlant Biotechnologies Ltd. in 2019; Independent Non-Executive Director at Xeris Pharmaceuticals, Inc. from 2016 to 2019; Principal at Merck & Co., Inc.; Vice President-Business Development at Aradigm Corp.
from 2002 to 2006; and Head-Business Development & Sales at Respironics Ltd. from 1995 to 2002.
Education includes undergraduate studies at The University of Sheffield and an MBA from the University of Portsmouth.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 22/09/2026 | 42.728 ( 0,03% ) | 18 159 $ | 31/10/2026 | |
| 14/04/2026 | 229.877 ( 0,06% ) | 17 471 $ | 31/10/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| SERNOVA BIOTHERAPEUTICS INC | Amministratore Delegato | 12/08/2024 |
| BIOPLUS ACQUISITION CORP. | Presidente | 01/07/2021 |
| ONCOLYTICS BIOTECH INC. | Direttore/Membro del Consiglio | 30/08/2022 |
Association of Needle-Free Injection Manufacturers | Presidente | 07/09/2010 |
ImmunoMolecular Therapeutics, Inc.
ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno-therapeutic drugs for autoimmune diseases | Direttore/Membro del Consiglio | 27/01/2021 |
Thermalin, Inc.
Thermalin, Inc. Pharmaceuticals: MajorHealth Technology Develops insulin treatments for patients with diabetes | Direttore/Membro del Consiglio | - |
ReAlta Life Sciences, Inc.
ReAlta Life Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops novel class of drugs with dual-targeting therapeutic capabilities | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
Revolo Biotherapeutics Ltd.
Revolo Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops immunologic and inflammatory medications | Amministratore Delegato | 22/02/2024 |
| STEADYMED LTD | Amministratore Delegato | 01/01/2020 |
| ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 18 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Aradigm Corp.
Aradigm Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes products for the treatment and prevention of respiratory diseases | Health Technology |
Oncolytics Biotech, Inc.
Oncolytics Biotech, Inc. BiotechnologyHealth Technology Discovers and develops pharmaceutical products for the treatment of cancers | Health Technology |
Sernova Biotherapeutics, Inc.
Sernova Biotherapeutics, Inc. BiotechnologyHealth Technology Develops life science products | Health Technology |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ready-to-use and liquid-stable injectables | Health Technology |
Zogenix, Inc.
Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets medicines | Health Technology |
Respironics Ltd.
Respironics Ltd. Financial ConglomeratesFinance Develops and manufactures medical and healthcare products | Finance |
The University of Sheffield
The University of Sheffield Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Portsmouth
University of Portsmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Association of Needle-Free Injection Manufacturers | |
SteadyMed Therapeutics, Inc.
SteadyMed Therapeutics, Inc. Medical/Nursing ServicesHealth Services Develops drug delivery therapeutics devices | Health Services |
Thermalin, Inc.
Thermalin, Inc. Pharmaceuticals: MajorHealth Technology Develops insulin treatments for patients with diabetes | Health Technology |
CollPlant Biotechnologies Ltd.
CollPlant Biotechnologies Ltd. Medical SpecialtiesHealth Technology Develops and commercializes medical devices | Health Technology |
SteadyMed Ltd.
SteadyMed Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, and manufacture of pharmaceutical products | Health Technology |
ImmunoMolecular Therapeutics, Inc.
ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno-therapeutic drugs for autoimmune diseases | Health Technology |
Revolo Biotherapeutics Ltd.
Revolo Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops immunologic and inflammatory medications | Health Technology |
ReAlta Life Sciences, Inc.
ReAlta Life Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops novel class of drugs with dual-targeting therapeutic capabilities | Health Technology |
BioPlus Acquisition Corp.
BioPlus Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale